"Steris Corp. (NYSE: STE), the world's leading maker of sterilization and decontamination equipment, is a fast-growing company in a recession-proof industry," notes growth stock expert Alexander Green.
The contributing editor to industry-leading The Oxford Club explains, "Every year, 6.5 billion medical devices are sterilized in Steris equipment. Even gun-shy investors can afford to step up and buy a few shares of this one."
"Researchers and professionals in the pharmaceutical, medical device manufacturing and health care industries count on Steris to keep their environments germ-free.
"In North America, Steris leads in products like lights, booms and tables. It also offers consumable products, such as hand sanitizers, washing lotions and skincare products.
"This company has a long history, datingo its beginnings as The American Sterilizer Company in 1894. It was already a world leader in sterilization products in the 19th century. Today, the company employs more than 5,300 people in more than 60 countries. Sales hit $1.32 billion over the past 12 months.
"And under the leadership of new CEO Walt Rosebrough, Steris is re-energizing its sales, marketing and R&D. It's also cutting costs to enhance efficiencies and improve profits.
"For three straight quarters, earnings have grown by at least 31%. Profits are still accelerating, in fact. Recently reported second-quarter earnings were up 92%. Revenue jumped 10% to $323.1 million.
"Steris stays on the cutting edge by adapting emerging technologies to meet customers' needs. The company has more than 220 U.S. and 464 international patents issued or pending. Demand for its products is growing, too.
"And, fortunately, Steris operates in a highly predictable industry. The demand for sterilization of hospital instruments is not going to change anytime soon. Of the roughly 5,000 hospitals in the United States, more than 80% use Steris' equipment or consumable products.
"In addition, awareness of infection control is growing around the world. Currently, 77% of sales are domestic. But Steris is rapidly expanding into international markets, too. The company is making a big push into both Asia and Latin America, in particular.
"In short, this is a fast-growing company in a recession-proof industry. It has a solid balance sheet, great management and excellent growth prospects. Buy Steris Corp. at market and use our customary 25% trailing stop to protect your principal and your profits."
Steven Halpern's TheStockAdvisors.com offers a daily look at the latest market commentary and favorite stock picks and investment ideas from the nation's leading financial newsletter advisors.
Nuclear power is on the comeback trail
Apple backs AT&T in continuing spat with Verizon
Closing Bell: The recession is still over, still... do you feel it?
Reader Comments (Page 1 of 1)
12-16-2008 @ 11:04AM
Greg said...
They mean cutting costs by slashing American workers and moving the operation to mexico. They did it here in Erie, PA. Greed. Greed. Greed.
1-13-2009 @ 6:47PM
Peter said...
You will lose money investing in Steris, not because germ killing isn't a recession proof growth business, it is, but because emerging technologies and approaches will displace Steris's aging intellectual
property and the ineffectiveness of its products to combat hospital acquired infections. Steris has a not invented here
mentally, and that will sink it.